SIGA Technologies Inc

SIGA · Moat type: REGULIERUNG

MoatScore

3/10

Fair Value

12 USD

Margin of Safety

+71.0 %

Rating

BEOBACHTEN

SIGA Technologies Inc. develops and markets antiviral medications to combat bioterrorism threats, primarily TPOXX (Tecovirimat) against smallpox and related orthopoxviruses, and generates revenues substantially through government procurement contracts with the U.S. Department of Health and Human Services (BARDA) as well as international governments.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.